Observational studyFrontiers in immunology2026

Zanubrutinib-based regimen as the salvage or bridging treatment of CART therapy in relapsed or refractory, non-germinal center B-cell-like diffuse large B-cell lymphoma: a retrospective multicenter cohort study.

Yan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.